Patent ID: 11945822
Assignee: LEAD DISCOVERY CENTER GMBH
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 4:
5. The compound according to claim 1, having the general formula IV, wherein X, and R2 are as defined in claim 1;
wherein Q1 is either absent or independently, at each occurrence, selected from the group consisting of aryl optionally substituted with one or two of C1-C6 alkyl, —OR5, —N(R5)R5, and halogen; heteroaryl optionally substituted with one or two of C1-C6 alkyl, —OR5, —N(R5)R5 and halogen; and heterocyclyl optionally substituted with one or two of R29 and R30;
R29 is either absent or independently, at each occurrence, selected from the group consisting of hydrogen, —Ole, halogen, —N(R5)R5, —NR9R12, —NH(C═O)R5, —(C═O)NH2, aryl, heteroaryl, heterocyclyl, C1-C6 alkyl and C1-C6 alkyl substituted with —OH or —NH2;
R30 is, independently, at each occurrence, selected from the group consisting of hydrogen, halogen, —OR5, —N(R5)R5, (═O), aryl, heteroaryl, heterocyclyl, C1-C6 alkyl and C1-C6 alkyl substituted with —OH or —NH2;
L2 is either absent or independently, at each occurrence, selected from the group consisting of —O—, —NH—, —(C═O)— and —(C═O)NH—;
Y1 is, independently at each occurrence, selected from CH, C(OH) and N;
Y2 is, independently at each occurrence, selected from CH, CR30, O and N;
m is, independently at each occurrence, selected from 0, 1 and 2;
n is, independently at each occurrence, selected from 0 and 1;
wherein Z1 is, and wherein R6, R7, R8, R9 and R10 are as defined in claim 1.